Stockscreener 앱 받기
104.94
0.18%
0.19
시간 외 거래:
102.00
-2.94
-2.80%
Spruce Biosciences Inc 주식(SPRB)의 최신 뉴스
Spruce Biosciences (SPRB) Expected to Announce Earnings on Monday - MarketBeat
One new option listing and two option delistings on September 5th - MSN
Small Cap Stocks To Follow TodayOctober 6th - MarketBeat
Spruce Biosciences (SPRB) Price Target Decreased by 37.30% to 6.40 - MSN
[S-3] SPRUCE BIOSCIENCES, INC. Shelf Registration Statement | SPRB SEC FilingForm S-3 - Stock Titan
Spruce Biosciences, Inc. (NASDAQ:SPRB) Given Average Rating of "Hold" by Brokerages - MarketBeat
Spruce Biosciences (NASDAQ:SPRB) Upgraded to "Outperform" at Citizens Jmp - MarketBeat
Spruce Biosciences Stock Rallied 1184%Have You Assessed the Risk - Trefis
JMP Securities Upgrades Spruce Biosciences (SPRB) - Nasdaq
Cash per share of Spruce Biosciences, Inc. – NASDAQ:SPRB - TradingView
SPRB: JMP Securities Upgrades Spruce Biosciences to Market Outpe - GuruFocus
Spruce Biosciences Raised to Market Outperform From Market Perform by JMP Securities - 富途牛牛
Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy - Investing.com Nigeria
Spruce Biosciences Stock Dropped 16%Have You Assessed the Risk - Trefis
Spruce Biosciences (NASDAQ:SPRB) Stock Rating Lowered by Zacks Research - MarketBeat
What is Leerink Partnrs' Forecast for SPRB FY2025 Earnings? - MarketBeat
Levi & Korsinsky Reminds Spruce Biosciences Investors of the Ongoing Investigation into Potential Violations of Securities LawsSPRB - ACCESS Newswire
Spruce Biosciences CFO vests 2,053 RSUs; owns 6,066 shares - Stock Titan
SPRB insider filing: CEO nets 3,245 shares after RSU vest - Stock Titan
The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting - Healthcare Brew
Leerink Partners Maintains Spruce Biosciences (SPRB) Market Perform Recommendation - Nasdaq
Spruce Biosciences (SPRB): Analyst Raises Price Target Significa - GuruFocus
Spruce Biosciences stock price target raised to $160 from $10 at Leerink - Investing.com Philippines
Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025) - ts2.tech
Mintz Advises the Placement Agents in Spruce Biosciences, Inc.’s $50 Million Private Placement - Mintz
Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough News – Experts Weigh In - ts2.tech
Spruce Biosciences (NASDAQ:SPRB) Upgraded at Zacks Research - Defense World
SPRUCE BIOSCIENCES, INC. trading resumes - MSN
Spruce Biosciences (NASDAQ:SPRB) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
SPRB director steps down; company notes no disagreement - Stock Titan
Spruce Biosciences, Inc. Announces Resignation of Bali Muralidhar as Member of Board of Directors and as Member of the Compensation Committee of the Board, Effective October 15, 2025 - MarketScreener
Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease - MSN
Head to Head Contrast: PyroGenesis Canada (NASDAQ:PYRGF) vs. Spruce Biosciences (NASDAQ:SPRB) - Defense World
What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now? - sharewise.com
Spruce Biosciences’ (SPRB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Spruce Biosciences insider filing shows 256-share buy, 1,050 held - Stock Titan
Spruce Biosciences to sell 502,181 shares at $68.00 in private placement - MSN
Spruce Biosciences' (SPRB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Spruce Biosciences (NASDAQ:SPRB) Shares Down 1%What's Next? - MarketBeat
Spruce Biosciences (NASDAQ:SPRB) Shares Down 1% – What’s Next? - Defense World
Medical Stocks To ConsiderOctober 6th - MarketBeat
Promising Pharmaceutical Stocks Worth WatchingOctober 6th - MarketBeat
$SPRB stock is down 11% today. Here's what we see in our data. - Quiver Quantitative
Spruce Biosciences, Inc. announced that it has received $49.999769 million in funding - MarketScreener
Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 By Investing.com - Investing.com Canada
Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 - Investing.com India
SPRUCE BIOSCIENCES, INC. trading halted, volatility trading pause - MSN
Spruce Biosciences announces $50M private placement financing - TipRanks
Spruce Biosciences (SPRB) Secures $50M for Therapy Advancements - GuruFocus
Three Biotech Stocks Jump After Big Regulatory Wins - Finimize
Spruce Biosciences (SPRB) Secures $50M for Enzyme Replacement Th - GuruFocus
Spruce Biosciences to Raise $50 Million Through Private Placement; Shares Down Pre-Bell - MarketScreener
Spruce Biosciences (SPRB) Secures $50 Million for Enzyme Therapy Development - GuruFocus
1.45%
0.86%
자본화:
|
볼륨(24시간):